As a news reporter, Ayisha Sharma focuses on the UK and Europe biopharma space and has an interest in psychiatric drug R&D. Ayisha joined Endpoints from Scrip, where she spent nearly two years covering the commercial implications of clinical trial readouts, drug approvals and industry dealmaking. Prior to this, she was an investigative journalist at GlobalData Insights. Ayisha holds an MA in Philosophy from University College London as well as a diploma in multimedia journalism. In her spare time, she enjoys running, yoga and watching horror films.